Cellular and Molecular Mechanisms in Cardiorenal Syndrome

A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Biology".

Deadline for manuscript submissions: 28 February 2026 | Viewed by 711

Special Issue Editors


E-Mail Website
Guest Editor

E-Mail Website
Guest Editor
Complejo Hospitalario, Universitario de Granada, Granada, Spain
Interests: kidney; nephrology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Medicine, University of Granada, Granada, Spain
Interests: kidney; gut; nephrology

Special Issue Information

Dear Colleagues,

Cardiorenal syndrome consists of an acute or chronic dysfunction of both the heart and kidney due to interactions between these organs. These interactions that are common in healthy individuals in order to maintain homeostasis are impacted when normal function of any of these organs is altered. There is a wide number of pathologies that can lead to cardiorenal syndrome. These pathologies can be of renal or cardiac origin. Renin–angiotensin–aldosterone system activation, mitochondrial dysfunction, inflammation, fibrosis, oxidative stress and tissue remodelling are related to organ dysfunction in patients with cardiorenal syndrome. Therefore, different mechanisms that implicate several molecular systems can worsen the cardiorenal syndrome. In-depth knowledge of the molecular mechanisms that are involved in cardiorenal syndrome might help us to understand the pathophysiological basis of this syndrome. In the same way, knowledge of these molecular mechanisms is essential for the research of novel therapeutical approaches that can be useful in the management of these patients. The goal of this Special Issue is to publish experimental and pre-clinical research articles or scientific reviews that study cellular and molecular mechanisms involved in cardiorenal syndrome. Articles can also be focused on the study of pharmacological approaches or pre-clinical assays that improve the progression of this syndrome.

Prof. Dr. Rosemary Wangensteen
Dr. María Carmen Ruiz Fuentes
Dr. Maria José Espigares Huete
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cardiorenal syndrome
  • renal failure
  • heart
  • kidney
  • heart failure

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 791 KB  
Article
Assessment of Cardiorenal Involvement in Systemic Sclerosis Patients
by Chiara Pellicano, Giancarlo D’Ippolito, Annalisa Villa, Ottavio Martellucci, Umberto Basile, Valeria Carnazzo, Valerio Basile, Edoardo Rosato, Mariapaola Marino and Antonietta Gigante
Biomolecules 2025, 15(9), 1297; https://doi.org/10.3390/biom15091297 - 9 Sep 2025
Viewed by 337
Abstract
Systemic sclerosis (SSc) is an autoimmune disease associated with a high burden of morbidity and mortality due to organ complications. Pulmonary arterial hypertension (PAH) and cardiac involvement, characterized by chronic right ventricular (RV) pressure overload with consequent RV dysfunction and ultimately right heart [...] Read more.
Systemic sclerosis (SSc) is an autoimmune disease associated with a high burden of morbidity and mortality due to organ complications. Pulmonary arterial hypertension (PAH) and cardiac involvement, characterized by chronic right ventricular (RV) pressure overload with consequent RV dysfunction and ultimately right heart failure (HF), are among these. A common comorbidity in SSc is chronic kidney disease (CKD). CKD is often present at the time of PAH diagnosis or a decline in renal function may occur during the course of the disease. CKD is strongly and independently associated with mortality in patients with PAH and HF. The cardiovascular and renal systems are closely interconnected, and disruption of this balance may result in cardiorenal syndrome (CRS). Type 2 CRS refers to CKD as a consequence of chronic HF. In clinical practice, non-specific markers such as troponin, B-type natriuretic peptide (BNP), N-terminal pro-BNP (NT-proBNP), and serum creatinine aid in CRS diagnosis. More specific biomarkers, including cystatin C (CysC), neutrophil gelatinase-associated lipocalin (NGAL), galectin-3, and soluble urokinase plasminogen activator receptor (suPAR), have shown value for diagnosis and prognosis in CRS. This study aimed to evaluate comprehensively heart/kidney damage markers related to CRS in SSc patients compared with healthy controls (HC) and to examine their association with renal and cardiac ultrasound parameters. SSc patients showed significantly higher CRS markers than HC (p < 0.001). SSc patients with clinically diagnosed CRS had significantly elevated galectin-3, suPAR, sNGAL, and uNGAL levels (p < 0.05) than SSc patients without CRS. Positive correlations were found between renal resistive index (RRI) and NT-proBNP (r = 0.335, p < 0.05), and between RRI and suPAR (r = 0.331, p < 0.05). NT-proBNP, suPAR, galectin-3, sNGAL, and uNGAL emerge as promising biomarkers for the early detection of cardiac and renal involvement in SSc patients. Full article
(This article belongs to the Special Issue Cellular and Molecular Mechanisms in Cardiorenal Syndrome)
Show Figures

Figure 1

Back to TopTop